Completed PHASE2 INTERVENTIONAL 2-arm NCT04703361

Effects of Ketones and Niacin in Heart Failure Patients (KETO-COX)

Sponsor: University of Aarhus

Conditions Heart Failure, Systolic Ketonemia

Interventions Na-3-OHB Niacin Placebo NaCl

Updated 5 times since 2021 Last updated: Dec 2, 2021 Started: Feb 15, 2021 Primary completion: Sep 3, 2021 Completion: Sep 3, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Heart Failure, Systolic and Ketonemia and is currently completed. University of Aarhus leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2022 — Jul 2024 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Mar 2021 — Jan 2022 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Feb 2021 — Mar 2021 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Aarhus

Data source: University of Aarhus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aarhus, Denmark